Amos Katz, MD
Neurology · Eatontown, NJNPI 1952411340
Payments from drug & device makers
Across 1,540 payments — averaging $790.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$700K
- Biogen$142K
- E.r. Squibb & Sons, L.L.C.$81K
- TG Therapeutics, Inc.$75K
- Sanofi$64K
- Genentech USA, Inc.$63K
- plus $93K from 28 others
Across 2 payments — averaging $317.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$634
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 266 | $700,196 |
| Biogen | 266 | $141,811 |
| E.r. Squibb & Sons, L.L.C. | 75 | $80,614 |
| TG Therapeutics, Inc. | 81 | $75,155 |
| Sanofi | 111 | $63,858 |
| Genentech USA, Inc. | 131 | $63,015 |
| Bristol Myers Squibb | 115 | $30,461 |
| AbbVie(2 entities) | 149 | $29,269 |
| Johnson & Johnson | 77 | $13,502 |
| EMD Serono, Inc. | 118 | $7,641 |
| AstraZeneca | 30 | $4,637 |
| Amgen(2 entities) | 24 | $4,632 |
| Banner Life Sciences, LLC | 2 | $817 |
| Avanir Pharmaceuticals, Inc. | 14 | $307 |
| Teva Pharmaceuticals USA, Inc. | 17 | $202 |
| Mallinckrodt Hospital Products Inc. | 11 | $164 |
| Otsuka America Pharmaceutical, Inc. | 3 | $153 |
| Lundbeck LLC | 10 | $148 |
| Biohaven Pharmaceuticals, Inc. | 3 | $132 |
| Mallinckrodt Enterprises LLC | 6 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $57 |
| Ipsen Biopharmaceuticals, Inc | 4 | $56 |
| Insulet Corporation | 2 | $54 |
| Pfizer | 3 | $52 |
| Merz Pharmaceuticals, LLC | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 3 | $48 |
| ANI Pharmaceuticals, Inc. | 3 | $47 |
| Medtronic(2 entities) | 2 | $41 |
| Acorda Therapeutics, Inc | 2 | $27 |
| Sequel Med Tech, LLC | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| IBSA Pharma Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $12 |
| Cycle Pharmaceuticals Inc | 1 | $12 |
How this compares
$1,217,299 in reported general payments places this provider in the 95th percentile of 521 neurology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Eatontown
- Mary Ann PiconeTeaneck$2.8M
- Steven BromleyAudubon$1.7M
- David DuncanNeptune$1.5M
- Lana Zhovtis RyersonNeptune$1.3M
- Fiona GuptaOradell$1.1M
- Andrew SylvesterBridgewater$1.1M
- Machteld HillenNewark$999K
- Matthew TremblayLivingston$812K
- Noah GilsonWest Long Branch$800K
- Matthew DavisMiddletown$785K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.